FGEN (FibroGen, Inc.) Kacepetan wutah bathi saben saham ing taun lumaku
A critical capital reduction and the threat of delisting following failures with pamrevlumab have placed serious pressure on FibroGen, Inc. (FGEN). FibroGen, Inc. (FGEN) generates revenue from the commercialization of fibrosis and anemia treatments, including partner payments. The brand's scientific authority is confirmed by the success of roxadustat. Looking at the annual earnings per share change on GURU.Markets, we see that the value of this metric is 61.80.
Rincian metrik keuangan lan pasar FibroGen, Inc. (FGEN)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- rincian utang lan likuiditas:
Koefisien Total Utang marang Modal FibroGen, Inc.|FGEN - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas fibrogen.com|FGEN - Utang perusahaan|Rasio utang marang aset resik FibroGen Corporation|FGEN - Utang jangka dawa perusahaan|Utang jangka cendhak FibroGen|Likuiditas kritis fibrogen.com
- indikator pendapatan resik lan kelipatan nilai:
FGEN - Bathi resik|Bathi resik sing dikarepake FibroGen, Inc.|FGEN - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep FibroGen Corporation|FGEN - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan FibroGen Corporation|FGEN - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan FibroGen|FGEN - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan fibrogen.com|FGEN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep FibroGen, Inc.
Analisis dhasar perusahaan:FibroGen Inc (FGEN)
This metric measures the year-over-year dynamics of net earnings per share, determining the growth or decline rates of the business's actual earnings over a twelve-month period. By analyzing the annual EPS growth indicator, an investor filters out market noise. For FibroGen, Inc. (FGEN), this reflects the commercialization efficiency of the drug Evaren within the nephrology segment. A positive trend confirms the successful substitution of injections with the oral form.
Pesaing utama
Haleon PLC - Tambahing bathi saben saham ing taun lumaku|KVUE (Kenvue Corp) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Verona Pharma Inc. VRNA|Wutah bathi saben saham ing taun lumaku Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku AMRX (Amneal)|PRGO (Perrigo Company PLC) - Dinamika bathi saben saham ing taun lumaku|Alvotech Corp - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Liquidia Inc. LQDA|GLPG: Wutah bathi ing taun lumaku|ANIP (anipharmaceuticals.com) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku MannKind|AMPH: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Pacira (PCRX)|SPRY - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku TBPH (Theravance Biopharma)|Owah-owahan bathi resik saben saham ing taun lumaku aquestive.com|scPharma - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Tectonic Therapeutic, Inc.|Tonix Pharmaceuticals Inc. (TNXP) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun iki SXTC|Wutah bathi resik saben saham ing taun iki EPRX|BHST: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku EXOZ|Prakiraan wutah bathi resik saben saham ing taun iki oramed.com|Wutah bathi saben saham ing taun lumaku Entera Bio ENTX|HYFT: Wutah bathi saben saham ing taun iki|ABVC BioPharma - Wutah bathi ing taun lumaku|cumberlandpharma.com (CPIX) - Wutah bathi resik saben saham ing taun iki|QNTM (Quantum BioPharma) - Wutah bathi resik saben saham ing taun iki|TELO - Prakiraan wutah bathi resik saben saham ing taun iki|RANI (Rani Therapeutics Holdings) - Wutah bathi ing taun lumaku|Synergy CHC Corporation - Dinamika bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku RLYB|lexariabioscience.com (LEXX) - Owah-owahan bathi resik saben saham ing taun lumaku|Wutah bathi ing taun lumaku PULM (Pulmatrix)|Pheton Holdings Limited (PTHL) - Kacepetan wutah bathi saben saham ing taun lumaku|APM - Wutah bathi saben saham ing taun lumaku|LYRA (Lyra Therapeutics Inc) - Wutah bathi saben saham ing taun iki|Impact BioMedical (IBO) - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku TNFA (TNF Pharmaceuticals, Inc.)|YCBD (cbdMD Inc.) - Wutah bathi ing taun lumaku|PRFX: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku CYTO|Wutah bathi ing taun lumaku Lipella Pharma (LIPO)|Wutah bathi saben saham ing taun lumaku OptiNose, Inc. OPTN|Tambahing bathi saben saham ing taun lumaku PIRS|PROC - Wutah bathi saben saham ing taun lumaku|Petros Pharmaceuticals Inc (PTPI) - Wutah bathi resik saben saham ing taun iki|QLI: Wutah bathi ing taun lumaku|ACELYRIN Inc. (SLRN) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki TFFP
